CDXS
Biotechnology · Healthcare
CEO, CTO
2024-09-30–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Codexis, Inc. publishes a filing, an earnings call transcript or a press release.
Get CDXS alertsAlison Moore, Ph.D. is recorded as CEO at Codexis, Inc. (CDXS) since November 7, 2025 and CTO at Codexis, Inc. (CDXS) since September 30, 2024. Codexis, Inc. reported in an 8-K filed November 6, 2025 that Alison Moore, Ph.D. was appointed Class III director, effective November 7, 2025. Codexis, Inc. reported in an 8-K filed November 6, 2025 that Alison Moore, Ph.D. was appointed President and Chief Executive Officer, effective November 7, 2025. Codexis, Inc. reported in an 8-K filed October 2, 2024 that Alison Moore, Ph.D. resigned as member of the Board and its committees, effective September 30, 2024. Equibles holds 4 filed executive changes naming Alison Moore, Ph.D.; each is listed under recent activity with its source filing. Alison Moore, Ph.D. has spoken on 1 investor event across 1 company, most recently for Codexis, Inc. on June 17, 2026. Codexis, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Codexis, Inc. includes Alison Moore (CEO and Board Member), Dr. Stephen Dilly (CEO), Georgia Erbez (CFO) and 7 others.
“On November 5, 2025, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Alison Moore, Ph.D., as a Class III director of the Board and as the President and Chief Executive Officer of the Company, replacing Stephen Dilly, M.B.B.S., Ph.D., effective as of November 7, 2025.”
“On November 5, 2025, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Alison Moore, Ph.D., as a Class III director of the Board and as the President and Chief Executive Officer of the Company, replacing Stephen Dilly, M.B.B.S., Ph.D., effective as of November 7, 2025.”
“I will act as chair of the annual meeting. The meeting will now officially come to order. The time is now 9 o'clock Pacific Time on Wednesday, June 17, 2026, and the polls are now open for voting on all matters to be presented.”
2025-11-07–present
2024-09-30–present
2025-11-07–2024-09-30
CDXS
Biotechnology · Healthcare
CEO, CTO
2024-09-30–present